Synbio Technologies will attend the 13th annual Essential Protein Engineering Summit (PEGS), May 1-5, 2017, at the Seaport World Trade Center in Boston, Massachusetts.
FOR IMMEDIATE RELEASE
Visit our booth, #112, to learn more about Synbio Technologies’ advanced “GPS” (Genotype, Phenotype and Synotype) platforms and comprehensive biological solutions. Our scientific capabilities encompass areas such as: DNA engineering, DNA synthesis, genome synthesis, pathway synthesis, synthetic biology, pharmacogenomics, microbiology, translational biology and the various applications of synthetic biology. All of these applications have been put to use in various fields of both biological and genetics research. They have advanced what is known on these subjects with relative ease.
We will be presenting our latest technological advances for the following services:
• Syno®3.0 Gene Synthesis – starting at $0.09/bp
• Metabolic Pathway Design and Synthesis
• Syno®DNA Library Design and Synthesis
• CRISPR-Cas9 Gene/Genome Editing
• Protein Expression and Purification
• Syno®Ab and GenoTM Ab Antibody Discovery Platforms
About Synbio Technologies:
With the breakthroughs in synthetic biology and system biology, de novo synthesized DNA and RNA molecules or variant libraries are widely used in pharmaceutical, agriculture, biofuel and biological/chemical production. As our understanding of DNA sequences (Genotype) and biological functions (Phenotype) increases, the ability to design and synthesize (Synotype) genes, genomes, pathways, and organisms by using synthetic biology techniques is also improving quickly. Synbio Tech. has created the comprehensive Synotype platforms for biological researchers that dedicate to integrating the cutting edge synthetic biology techniques and bio-informatic tools into an advanced biological innovation platform. Synbio Technologies is a DNA technology company, focusing on the next generation DNA synthesis and its applications. We have built up the first integrated GPS (Genotype-Phenotype-Synotype) system aimed to a quick and easy translation or reverse translation between “Genotype” and “Phenotype” by using our proprietary “Synotype” platform. The company’s scientific capabilities encompass areas such as DNA engineering, DNA synthesis, genome synthesis, pathway synthesis, synthetic biology, pharmacogenomics, microbiology, translational biology and the applications of synthetic biology. Synbio Technologies’ team has a proven track record regarding translating scientific breakthroughs into cost effective biological solution.